Pharma BD Deal Intelligence
King Pharmaceuticals Inc. / Bristol-Myers Squibb (Corgard/Corzide/Delestrogen/Florinef rights)
2001 · Asset Purchase · $285M · Complete
Announcement Sentiment
75
Strongly positive
King paid BMS ~$285M cash for US rights to Corzide, Delestrogen, Florinef plus fully-paid Corgard license. Asset purchase, not entity.
Key facts
- Announced Aug 08, 2001
- Deal value $285M
- Deal type Asset Purchase
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals